With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an impressive resume already, but it's just getting started. It's currently in the ...
To get a head start on getting into the proper headspace for the busy months ahead, the Arkansas Times proudly presents another round of cannabis recommendations from some of Arkansas’s best ...